...
首页> 外文期刊>European review for medical and pharmacological sciences. >MiR-381-3p inhibits proliferation, migration and invasion by targeting LRP6 in papillary thyroid carcinoma
【24h】

MiR-381-3p inhibits proliferation, migration and invasion by targeting LRP6 in papillary thyroid carcinoma

机译:miR-381-3p通过靶向乳头状甲状腺癌中的LRP6来抑制增殖,迁移和侵袭

获取原文
           

摘要

OBJECTIVE: MiR-381-3p plays an essential role in the progression of a variety of cancers, but its expression and role in papillary thyroid carcinoma (PTC) progression have not been investigated. The aim of this study was to investigate the expression of miR-381-3p and its function in PTC. PATIENTS AND METHODS: The expression levels of miR-381-3p and low-density lipoprotein receptor?related protein 6 (LRP6) mRNA in PTC tissues and cell lines were measured using RT-PCR. Cell proliferation, migration and invasion were assessed by cell viability assay and transwell assay. Luciferase assays and Western blotting were performed to demonstrate miR-381-3p target gene. RESULTS: We found that miR-381-3p was significantly down-regulated in PTC tissues and cell lines. In vitro assay indicated that up-regulation of miR-381-3p significantly suppressed PTC cell proliferation, migration and invasion. Moreover, luciferase reporter gene assay demonstrated that miR-381-3p could target LRP6 by binding to the 3’ UTR. Western blot and Reverse transcription?quantitative polymerase chain reaction (RT?qPCR) showed that miR-381-3p overexpression suppressed the expression of LRP6 at both mRNA and proteins levels. In addition, functional experiment confirmed that LRP6 was involved in the suppressive effect of miR-381-3p-mediated PTC on cell proliferation, migration and invasion. CONCLUSIONS: Our findings suggested, for the first time, that miR-381-3p was lowly expressed in PTC tissues, and its up-regulation inhibited tumorigenesis of PTC by targeting LRP6.
机译:目的:MiR-381-3P在各种癌症的进展中起重要作用,但其表达和在乳头状甲状腺癌(PTC)进展中的作用尚未得到调查。本研究的目的是探讨miR-381-3p的表达及其在PTC中的功能。患者和方法:使用RT-PCR测量PTC组织和细胞系中的miR-381-3p和低密度脂蛋白受体α相关蛋白6(LRP6)mRNA的表达水平。通过细胞活力测定和Transwell测定评估细胞增殖,迁移和侵袭。进行荧光素酶测定和蛋白质印迹以证明miR-381-3p靶基因。结果:我们发现MiR-381-3P在PTC组织和细胞系中显着下调。体外测定表明miR-381-3p的上调显着抑制了PTC细胞增殖,迁移和侵袭。此外,荧光素酶报告基因测定证明MIR-381-3P可以通过与3'UTR结合来靶向LRP6。 Western印迹和逆转录α定量聚合酶链反应(RT≥β)显示MIR-381-3P过表达抑制了MRNA和蛋白质水平的LRP6的表达。此外,功能实验证实,LRP6涉及MIR-381-3P介导的PTC对细胞增殖,迁移和侵袭的抑制作用。结论:我们的研究结果表明,MIR-381-3P在PTC组织中差低表达,其上调通过靶向LRP6抑制PTC的肿瘤瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号